TRIMTECH Therapeutics brings total seed round to $47 M with additional investment of $14 M to further develop TRIMTAC and TRIMGLUE targeted protein degradation portfolio News-Medical.Net 13:23 Tue, 23 Jun
Trimtech Therapeutics Brings Total Seed Round to $47M with Additional Investment of $14M to Further Develop Trimtac and Trimglue Targeted Protein Degradation Portfolio Business Wire (Press Release) 10:42 Tue, 23 Jun